Nationwide Fund Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Nationwide Fund Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,878	Closed	-$324K	–	2278
2017 Q3	$324K	Hold	2,878	–	–	﹤0.01%	2398
2017 Q2	$323K	Sell	2,878 -930	-24%	-$105K	﹤0.01%	2406
2017 Q1	$444K	Sell	3,808 -730	-16%	-$80.8K	﹤0.01%	2218
2016 Q4	$478K	Sell	4,538 -10,000	-69%	-$1.05M	﹤0.01%	2195
2016 Q3	$1.61M	Hold	14,538	–	–	0.01%	1501
2016 Q2	$2.12M	Buy	14,538 +12,036	+481%	+$1.71M	0.01%	1330
2016 Q1	$358K	Buy	2,502 +1,046	+72%	+$149K	﹤0.01%	2264
2015 Q4	$225K	Buy	1,456 +1,356	+1,356%	+$198K	﹤0.01%	2484
2015 Q3	$14K	Hold	100	–	–	﹤0.01%	3155
2015 Q2	$14K	Hold	100	–	–	﹤0.01%	3186
2015 Q1	$14K	Hold	100	–	–	﹤0.01%	3204
2014 Q4	$15K	Hold	100	–	–	﹤0.01%	3116
2014 Q3	$15K	Buy	+100	New	+$15.1K	﹤0.01%	3196

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Nationwide Fund Advisors's TARO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 2,878 shares — an estimated $324K sold.

Nationwide Fund Advisors first reported a position in TARO in Q3 2014 and held it in 13 quarters. The position peaked at $2.12M in Q2 2016. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

Nationwide Fund Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
Nationwide Fund Advisors sold 2,878 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $324K.
Nationwide Fund Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2014 and held it in 13 quarters.
Nationwide Fund Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $2.12M in Q2 2016.
127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.